Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-844-8 | CAS number: 2550-06-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- The study was conducted according to a test protocol that is comparable to the appropriate OECD test guideline, and in compliance with GLP, with acceptable rextrictions. The restrictions were that only 1000 erythrocytes were scored for micronuclei. It is considered that read-across to the registered substance is scientifically justified.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- only 1000 PCE scored for micronuclei
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 3-chloropropyltrimethoxysilane
- EC Number:
- 219-787-9
- EC Name:
- 3-chloropropyltrimethoxysilane
- Cas Number:
- 2530-87-2
- IUPAC Name:
- (3-chloropropyl)(trimethoxy)silane
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- Swiss Webster
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River laboratories
- Age at study initiation: 5 weeks
- Weight at study initiation: 22.7 to 25.5 g (males); 17.9 to 21.4 g (females)
- Assigned to test groups randomly: yes, under following basis: nonstratified randomization proecedure based on body weight
- Fasting period before study: no
- Housing: group housed in shoe box type plastic cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22
- Humidity (%): 40-70%
- Air changes (per hr): no information
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 1991-07-08 To: 1991-09-03
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil;
- Justification for choice of solvent/vehicle: none given - standard vehicle - Details on exposure:
- Chloropropyltrimethoxysilane (CAS No. 2530-87-2) was given to both male and female Swiss-Webster mice as a single dose by intraperitoneal injection. Based upon mortality data obtained in a range-finding study, the acute intraperitoneal LD50 for the combined sexes was calculated to be 2031 mg/kg chloropropyltrimethoxysilane (95% confidence interval, 1672 to 2456 mg/kg). The doses for the definitive micronucleus assay were selected by the study director as approximately 25%, 50%, and 90% of the LD50 or 500, 1000, and 1625 mg/kg chloropropyltrimethoxysilane.
- Frequency of treatment:
- Single dose
- Post exposure period:
- 30, 48 and 72 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0 (corn oil), 500, 1000 or 1625 mg/kg
Basis:
- No. of animals per sex per dose:
- 5 per sex per dose, except high dose where 8/sex/dose were used
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- - triethylenemelamine
- dissolved in ethanol then diluted with sterile distilled water
- Justification for choice of positive control(s): none given, standard control
- Route of administration: ip
- Doses / concentrations:0.3 mg/kg
Examinations
- Tissues and cell types examined:
- Peripheral erythrocytes
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: based on toxicity data
DETAILS OF SLIDE PREPARATION: 1 or 2 blood smear slides prepared per animal, stained with Gurr's R-66 Giesma
METHOD OF ANALYSIS: PEC: PNEC ratio for 1000 cells per animal calculated to estimate toxicity. 100 PCE/animal scored for presence of micronuclei - Statistics:
- Mann-Whitney U test, probabilty value of <0.05 (1-tailed) used as critical level for significance.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- PCE/NCE ratio decreased at 72 h, high dose
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- There were no signs of toxicity in male or female mice in the 500 mg/kg group, except that 1 female exhibited ataxia during the first hour post-treatment. All of the males and females in the 1000 mg/kg group exhibited ataxia and 2 of the males also had tremors during the first hour after treatment. In males and females treated at 1625 mg/kg chloropropyltrimethoxysilane, ataxia, tremors, and prostration were observed during the first hour after treatment. Other clinical signs in the high dose females included myoclonic jerks and vocalization. There were no significant clinical observations in male or female mice from the afternoon of Day 1 through the end of the study.
There was a significant decrease in the polychromatophilic erythrocyte (PCE) to normochromatophilic erythrocyte (NCE) ratios at the 72 hr sampling time among male mice (50.6% of control) treated with 1625 mg/kg cloropropyltrimethoxysilane. However, there was no evidence that chloropropyltrimethoxysilane was excessively toxic to the bone marrow at the concentrations chosen for the study. No significant increases in the incidences of micronucleated PCE were observed at 500, 1000, or 1625 mg/kg chloropropyltrimethoxysilane at the 30, 48 or 72 hr sampling times in mice of either sex.
RESULTS OF RANGE-FINDING STUDY
- Dose range: information not included in study report
- Rationale for exposure: based on ip LD50
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): negative
- Ratio of PCE/NCE (for Micronucleus assay): decreased
- Appropriateness of dose levels and route: yes
- Statistical evaluation: yes
Any other information on results incl. tables
Treatment
|
Solvent control |
Low dose |
Mid dose |
High dose |
Positive control |
||
Sampling time |
|
30 h |
|||||
Number of erythrocytes |
normochromatic (NCE) |
m |
NR |
NR |
NR |
NR |
NR |
|
f |
NR |
NR |
NR |
NR |
NR |
|
|
polychromatic (PCE) |
m |
5000 |
5000 |
5000 |
5000 |
5000 |
|
f |
5000 |
5000 |
5000 |
5000 |
5000 |
|
|
PCE with micronuclei (MPCE) |
m |
12 |
13 |
15 |
12 |
061 |
|
f |
9 |
5 |
4 |
11 |
67 |
|
Ratio of erythrocytes |
PCE/1000 NCE |
m |
34 |
35 |
33 |
28.4 |
24.6 |
|
f |
28.4 |
35 |
29.6 |
29.0 |
28.4 |
|
|
MPCE/NCE (%) |
m |
0.24 |
0.26 |
0.30 |
0.24 |
1.22 |
|
f |
0.18 |
0.10 |
0.08 |
.22 |
1.34 |
|
Sampling time |
|
48 h |
|||||
Number of erythrocytes |
normochromatic (NCE) |
|
NR |
NR |
NR |
NR |
NE |
|
polychromatic (PCE) |
b |
10000 |
10000 |
10000 |
10000 |
NE |
Ratio of erythrocytes |
PCE with micronuclei (MPCE) |
|
20 |
24 |
16 |
17 |
NE |
|
PCE/1000 NCE |
m |
26.8 |
24.4 |
23.4 |
19.8 |
NE |
|
f |
24.8 |
23.2 |
22.4 |
23.8 |
NE |
|
|
MPCE/NCE (%) |
|
0.2 |
0.24 |
0.16 |
0.17 |
NE |
|
72 h |
||||||
|
polychromatic (PCE) |
b |
10000 |
10000 |
10000 |
10000 |
NE |
|
PCE with micronuclei (MPCE) |
b |
16 |
15 |
16 |
16 |
NE |
|
PCE/NCE (%) |
b |
0.16 |
0.15 |
0.16 |
0.16 |
NE |
|
MPCE/NCE
|
m |
35.2 |
30.8 |
26.8 |
17.8* |
NE |
|
f |
29.2 |
33.6 |
31.4 |
20.4 |
NE |
* significantly different from control, p<0.01
b both sexes combined
NR not recorded
NE not evaluated
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
In a valid study according to a protocol similar to OECD 473 and under GLP, Chloropropyltrimethoxysilane did not produce significant, treatment-related increases in the incidence of micronucleated polychromatophilic erythrocytes among male or female Swiss-Webster mice assessed at 30, 48 or 72 hours . It is concluded that the test substance is negative for the induction of micronuclei in periperal erythrocytes of mice under the conditions of the test.
after treatment with a single dose by intraperitoneal injection. Therefore, chloropropyltrimethoxysilane was not
considered to be an inducer of micronuclei in male or female Swiss-Webster mice under the conditions of the in vivo
assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.